CD68 and uveitis: A previous study using retrospective examination of tissues from EBOV-exposed NHPs identified EBOV in CD68+ macrophages particularly located at vitreo-retinal, vitreo-uveal, and vitreo-capsular interfaces in treated and untreated NHPs survivors; clinical uveitis was not noted during the in-life follow-up, but histopathology identified varying incidence of uveitis, vitritis, and retinitis16.